Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by their commitment to patients, their people and the planet.
Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). They also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
They are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging their enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.
Their employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.
OTHER INDUSTRIAL MEMBERS
Other research groups